Timothy J. Lorber
CIK: 0002027850
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Officer
Discretionary Trading P&L
Holdings
About Lorber Timothy J.
Lorber Timothy J. (SEC CIK 0002027850) files insider reports with the SEC as Chief Financial Officer of Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Signal8 holds 1 ownership filing by Lorber Timothy J., a Form 4, filed on Aug 12, 2025. Those filings report 2 transactions, the latest on Aug 8, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Lorber Timothy J.'s filings is in GAITHERSBURG, MD.
Recent filings by Lorber Timothy J.
- Aug 8, 2025: Grants or awards of SHPH derivative securities (2 lines, Form 4, code A).
Other insiders filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- HRT FINANCIAL LP, 10% Owner
- Trasolini Ryan, Co-Chief Executive Officer
- Liang Yuying, Chief Financial Officer
- Liriano Angel, Director
- Pathigoda Arachchige Sachin Eranga, Director
- Chambers Adam V, Director